Atypical antipsychotics: experience and use in the elderly

Area of Science:

• Geriatric Medicine
• Psychopharmacology
• Neurology

Background:

• Antipsychotic medications are frequently prescribed for elderly individuals.
• Typical antipsychotics present significant risks, including tardive dyskinesia, and have questionable efficacy.
• Atypical antipsychotics demonstrate a better side-effect profile and lower risk of tardive dyskinesia.

Purpose of the Study:

• To review the current literature on the efficacy and use of atypical antipsychotics in the elderly.
• To provide evidence-based recommendations for using common atypical antipsychotics in primary psychosis, Parkinson's disease, and behavioral and psychological symptoms of dementia (BPSD).

Main Methods:

• Systematic review of published literature on atypical antipsychotics in geriatric populations.
• Analysis of efficacy and safety data for common atypical antipsychotic agents.
• Synthesis of findings to formulate clinical recommendations.

Main Results:

• Limited published data exists on the efficacy of atypical antipsychotics in elderly patients across various conditions.
• Atypical antipsychotics appear to have a more favorable safety profile compared to typical antipsychotics in this demographic.
• Evidence for optimal use in primary psychosis, Parkinson's disease, and BPSD remains less established.

Conclusions:

• Atypical antipsychotics are generally preferred over typical antipsychotics for the elderly due to a better safety profile.
• Further research is crucial to establish definitive efficacy and optimal treatment strategies for atypical antipsychotics in elderly patients with psychosis, Parkinson's disease, and dementia-related behavioral symptoms.